CMCO · Columbus McKinnon Corporation · Stock research

Current Thesis

The leg on offer is unchanged in substance and worse in structure. What an investor buys here is deleveraging arithmetic: Credit Agreement Net Leverage of 4.9x at 2026-06-30 against a stated path below 4x by FY28, funded by $70M of targeted annual run-rate synergies from the $2.7B Kito Crosby acquisition that closed 2026-02-03. The 2026-07-30 print delivered on that frame — adjusted EPS $0.61 versus $0.27 consensus, sales $531.461M versus $501.262M consensus, guidance raised on all three lines — and the equity has since handed the move back. The 2026-08-21 close of $17.62 sits below the $20.22 close of 2026-08-07 and 23.4% under the $23.01 52-week high, with RSI(14) at 32.1, and it does so without a company headline since the 2026-08-05 rating maintenances. The shelf built by the July print is gone; the fundamental case now has to survive ten weeks of no company news before the Q2 FY27 print marks it.

Bullish and bearish views on Columbus McKinnon Corporation

The model's bull view on Columbus McKinnon Corporation (CMCO), in brief: The first full combined quarter cleared consensus by a wide margin. The bear view: The August decline arrived without a headline. Both cases follow in full.

Bull Case

• The first full combined quarter cleared consensus by a wide margin. Adjusted EPS $0.61 against $0.27 estimated; net sales $531.461M against $501.262M estimated (2026-07-30 release, quarter ended 2026-06-30).
• Order intake exceeded shipments. Orders $568.1M versus sales $531.5M gives a 1.1x book-to-bill for the June quarter; legacy Columbus McKinnon net sales grew 12.7% YoY on U.S. short-cycle demand per CEO David Wilson.
• Margin expanded on mix, synergies and input costs simultaneously. Adjusted gross margin 38.1% (+380bps YoY), adjusted EBITDA $111.5M at a 21.0% margin (+720bps YoY), per the 2026-07-30 release.
• All three FY27 guidance lines were raised in one release: sales to $2.09–2.15B from $2.05–2.12B, adjusted EBITDA to $405–420M from $390–410M, adjusted EPS to $1.90–2.10 from $1.70–1.90 against a $1.75 consensus. The EPS guide rests on published assumptions — 52M adjusted diluted shares, $135–140M amortization, $75–80M depreciation, 25% normalized tax — each checkable at the next print.
• Synergy capture is early-stage. Management signalled confidence in exceeding the original $70M annual run-rate target with Q1 realization weighted to SG&A, leaving the manufacturing and procurement tranches ahead.
• Price now sits below every published target. The four-analyst consensus stands at $26 with a $18–$30 range; the last two actions, both dated 2026-08-05, were maintenances — J.P. Morgan (James Kirby) Buy at $29 and D.A. Davidson (Matt Summerville) Hold at $18. The 2026-08-21 close of $17.62 is under the low end of that band.

Bear Case

• The August decline arrived without a headline. No company disclosure sits between the 2026-08-05 rating maintenances and the 2026-08-21 close of $17.62, and the 2026-08-14 annual meeting produced nothing that moved the name. Supply met a thin bid in a company whose common market capitalisation was $502.88M at that close.
• GAAP and adjusted results describe different companies. The June quarter produced a GAAP net loss of $88.7M, or −$2.05 per diluted share, against $30.5M of adjusted net income, with $135–140M of FY27 amortization guided. Screens built on reported earnings keep excluding the name.
• The fixed charge does not flex with demand. The FY27 interest assumption of $185–190M sits against a $405–420M adjusted EBITDA guide, on $1.65B of floating-rate Term Loan B, $900M of 7.125% senior secured notes due 2033 and a $500M revolver.
• Cash conversion has not shown up yet. Q1 operating cash flow $25.6M and free cash flow $20.0M ($32.4M excluding deal costs) against $111.5M of adjusted EBITDA. Total liquidity was $567.1M at 2026-06-30.
• The preferred ranks ahead of the common. CD&R holds $800M of Series A cumulative convertible participating preferred at a 7.0% dividend and a $37.68 conversion price, plus three of twelve board seats. The FY27 guide assumes 52M adjusted diluted shares against a common market capitalisation of $502.88M.
• Coverage is four analysts deep and dispersed $18 to $30. A name this thinly followed reprices on flow rather than on new information between quarters.

Setup & Price Structure

• Reference close 2026-08-21: $17.62. Distance from the $23.01 52-week high: −23.4%. Three-month price change: +18.3%. RSI(14): 32.1.
• The $18.50 area established by the 2026-07-30 guidance raise has been lost. The prior published break condition on this name was framed there and it has been taken out on a closing series, so the structure question is now whether the pre-print zone holds rather than whether the breakout extends.
• The narrative is maturing. The dating: the last fresh piece of news flow was J.P. Morgan's 2026-07-31 target raise to $29; the 2026-08-05 actions from both covering firms were maintenances rather than initiations or revisions; the 2026-08-14 annual meeting came and went; and the calendar holds no company event before the Q2 FY27 print in late October. The acquisition-and-deleveraging story is fully disclosed and now gets marked four times a year. Should the pre-print zone fail alongside a Q2 print that shows leverage rising, the correct label becomes dead, and this note would say so.
• Crowding and positioning observables, stated as observables: coverage is four analysts with a $26 consensus; the 2026-08-21 close is beneath the lowest published target of $18; RSI(14) at 32.1 is at the low end of its band rather than extended above a rising average; there is no earnings date inside 30 days, so no imminent event is compressing the flow; the quarterly dividend of $0.07 went ex on 2026-08-07 and paid 2026-08-17, removing that date from the near calendar. Nothing in the visible record shows the retail-sentiment clustering or issuance-into-strength pattern that marks a crowded long.

Catalyst Calendar (next 30 days)

• ~2026-09-01 — ISM Manufacturing PMI for August (first-business-day release). Legacy Columbus McKinnon's 12.7% growth was tied to U.S. short-cycle demand; the new-orders sub-index is the public proxy for whether the 1.1x book-to-bill held through the September quarter.
• ~2026-09-16 (est.) — September FOMC decision. $1.65B of Term Loan B is floating-rate, so the path of short rates feeds the $185–190M FY27 interest assumption directly.
• No company-scheduled event falls inside the window. The next company mark is the Q2 FY27 print, estimated ~2026-10-29, which should also carry the next dividend declaration.

What Would Change Our Mind

The structure that framed the prior read — the shelf the 2026-07-30 guidance raise built around $18.50 — has already failed on a closing series, and the 2026-08-14 annual meeting passed without producing a replacement catalyst. What remains gradeable from here: a weekly close below $16.50 would mark the post-print advance as fully unwound and put the shares more than 8% under the lowest published sell-side target of $18 (D.A. Davidson, 2026-08-05), at which point the equity is being priced as a levered stub rather than as a deleveraging story. On the fundamental side, the Q2 FY27 print (~2026-10-29, est.) showing Credit Agreement Net Leverage above the 4.9x posted at 2026-06-30, book-to-bill under 1.0x, or any reduction to the $2.09–2.15B FY27 sales guide or the $70M synergy target, would break the case independent of price. Management pushing the sub-4x leverage goal beyond FY28 does the same.

Working the other way: a Q2 print with leverage inside 4.9x, free cash flow converting toward the $111.5M quarterly adjusted EBITDA run-rate, and book-to-bill at or above 1.0x would restore the leg — that combination is what the late-October date exists to resolve.

Correlation Notes

• The equity behaves as a residual claim on EBITDA rather than as a typical mid-cap industrial: a $502.88M common market capitalisation at the 2026-08-21 close sits behind $2.55B of funded debt and $800M of preferred. Small changes in the EBITDA outlook translate into outsized equity moves in both directions.
• Sensitivity runs through U.S. short-cycle industrial demand — ISM new orders, lifting and rigging exposure to construction, energy and mining capex — and through high-yield credit conditions, since the deleveraging path assumes ordinary access to refinancing on the 2033 notes and the Term Loan B.
• Rate-path sensitivity is direct and mechanical via the floating-rate Term Loan B, which is unusual for an industrial of this size and decouples the name from unlevered peers on hawkish repricing.
• The FTC-required divestiture of U.S. power chain hoist and chain manufacturing closed 2026-03-04 and distorts YoY revenue comparisons through FY27, so screen-driven flow keyed to reported growth rates reads this name incorrectly for another three quarters.